Unusual cause of dyspnea in patient with Myelofibrosis: The Ruxolitinib lung

被引：0

作者：

El Kik, Antoine ^{[1
]}

Vander Kuylen, Maarten ^{[2
]}

Bailly, Benjamin ^{[3
]}

Fallas, Jennifer ^{[4
]}

Bondue, Benjamin ^{[1
]}

机构：

[1] Univ Libre Bruxelles, Hop Univ Bruxelles, Dept Pneumol, Brussels, Belgium

[2] Univ Libre Bruxelles, Hop Univ Bruxelles, Dept Thorac Surg, Brussels, Belgium

[3] Hop Louviere S Jolimont, Dept Hematol, Haine St Paul, Belgium

[4] Univ Libre Bruxelles, Hop Univ Bruxelles, Dept Pathol, Brussels, Belgium

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2024年 / 51卷

关键词：

Mycobacterium avium; Myelofibrosis; Pulmonary alveolar proteinosis; Ruxolitinib;

D O I：

10.1016/j.rmcr.2024.102090

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Although pulmonary complications are frequent in patients suffering from hematological diseases, secondary pulmonary alveolar proteinosis is a very rare complication of myelofibrosis. We describe the case of a 65-year-old male patient treated by Ruxolitinib for myelofibrosis who developed a secondary pulmonary alveolar proteinosis complicated by a Mycobacterium avium infection. We believe that this respiratory complication might be related to the myelofibrosis and to the initiation of the Ruxolitinib according to its temporal relationship. Pulmonologists should be aware that respiratory symptoms in myelofibrosis patients taking Ruxolitinib may be related to pulmonary alveolar proteinosis.

引用

页数：4

共 11 条

[1] The spectrum of GATA2 deficiency syndrome [J].

Calvo, Katherine R. ;

Hickstein, Dennis D. .

BLOOD, 2023, 141 (13) :1524-1532

[2]

Chaulagain Chakra P, 2014, Hematol Oncol Stem Cell Ther, V7, P127, DOI 10.1016/j.hemonc.2014.09.003

[3] Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies [J].

Huang, Xinmei ;

Cao, Mengshu ;

Xiao, Yonglong .

FRONTIERS IN IMMUNOLOGY, 2023, 14

[4] Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan [J].

Ishii, H. ;

Tazawa, R. ;

Kaneko, C. ;

Saraya, T. ;

Inoue, Y. ;

Hamano, E. ;

Kogure, Y. ;

Tomii, K. ;

Terada, M. ;

Takada, T. ;

Hojo, M. ;

Nishida, A. ;

Ichiwata, T. ;

Trapnell, B. C. ;

Goto, H. ;

Nakata, K. .

EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) :465-468

[5] Pulmonary alveolar proteinosis [J].

Jouneau, Stephane ;

Menard, Cedric ;

Lederlin, Mathieu .

RESPIROLOGY, 2020, 25 (08) :816-826

[6]

Kerget B, 2017, RESPIR MED CASE REP, V22, P243, DOI 10.1016/j.rmcr.2017.09.003

[7] Pulmonary arterial hypertension exacerbated by ruxolitinib [J].

Low, Andrew T. ;

Howard, Luke ;

Harrison, Claire ;

Tulloh, Robert M. R. .

HAEMATOLOGICA, 2015, 100 (06) :E244-E245

[8] Ruxolitinib-associated infections: A systematic review and meta-analysis [J].

Lussana, Federico ;

Cattaneo, Marco ;

Rambaldi, Alessandro ;

Squizzato, Alessandro .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (03) :339-347

[9] Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation [J].

Salvator, Helene ;

Berti, Enora ;

Catherinot, Emilie ;

Rivaud, Elisabeth ;

Chabrol, Alexandre ;

Nguyen, Stephanie ;

Zemoura, Leila ;

Cardot, Emilie ;

Tcherakian, Colas ;

Couderc, Louis-Jean .

EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (05)

[10] Secondary Pulmonary Alveolar Proteinosis Associated with Primary Myelofibrosis and Ruxolitinib Treatment: An Autopsy Case [J].

Sugiura, Hiroyuki ;

Nishimori, Hisakazu ;

Nishii, Kazuya ;

Toji, Tomohiro ;

Fujii, Keiko ;

Fujii, Nobuharu ;

Matsuoka, Ken-ichi ;

Nakata, Koh ;

Kiura, Katsuyuki ;

Maeda, Yoshinobu .

INTERNAL MEDICINE, 2020, 59 (16) :2023-2028

← 1 2 →